Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
about
The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old ageChemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's DiseaseDissociable effects of disconnecting amygdala central nucleus from the ventral tegmental area or substantia nigra on learned orienting and incentive motivationSensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease.Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synucleinMotor deficits and altered striatal gene expression in aphakia (ak) mice.Oxidation of survival factor MEF2D in neuronal death and Parkinson's diseaseNeuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in RatsDissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseasesNeuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.Evidence of D-phenylglycine as delivering tool for improving L-dopa absorptionProtective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model.Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner earHCN channelopathy in external globus pallidus neurons in models of Parkinson's disease.Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat modelA guide to neurotoxic animal models of Parkinson's diseaseEmbryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats.Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties.Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in ratsBiomaterial bridges enable regeneration and re-entry of corticospinal tract axons into the caudal spinal cord after SCI: Association with recovery of forelimb functionDifferential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.Effects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson's Disease Rat Model.PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice.Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics.Disrupted brain metabolic connectivity in a 6-OHDA-induced mouse model of Parkinson's disease examined using persistent homology-based analysis.Targeting the progression of Parkinson's disease.(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's disease.NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice.Therapeutic cloning in individual parkinsonian mice.The significance of neuronal lateralisation in Parkinson's disease.Oxidative stress in genetic mouse models of Parkinson's disease.The Anti-Parkinsonism Effects of KATP Channel Blockade in the 6-Hydroxydopamine-Induced Animal Model: The Role of Oxidative Stress.Heterotopic Mucosal Grafting Enables the Delivery of Therapeutic Neuropeptides Across the Blood Brain Barrier.Neurotransmitter release: vacuolar ATPase V0 sector c-subunits in possible gene or cell therapies for Parkinson's, Alzheimer's, and psychiatric diseases.Neurotoxic Effect of Benzo[a]pyrene and Its Possible Association with 6-Hydroxydopamine Induced Neurobehavioral Changes during Early Adolescence Period in Rats.Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.
P2860
Q21090191-5A7A22BD-684C-4AA4-BBD3-EE7A8566F021Q28829174-A886BB8A-C3DE-4FAA-AB7C-4DEBABBE69E6Q30482180-737D6D9F-DC96-40A6-8B32-0E47949E905DQ30512976-321B8156-5777-481F-AD0D-47DF3726117EQ30633819-DDCB1F2E-0713-4AAA-A142-C679CB3C714AQ33303267-D98D3EDF-CC63-442C-A375-DBC42DC3B78CQ33687858-9877FC19-52D9-4B30-880C-851AC38E8CF2Q33905707-815845D7-16D0-4590-A0D4-C3CA332A210AQ34063565-6DB7465B-365C-4A5B-9A07-728627D32A19Q34129621-2A17C00C-0B7D-4843-8CA3-72631D58D52EQ34137524-236C2B96-8222-4523-86B4-AFEC8E5C02E9Q34423923-0B564899-CF07-4171-BD11-661654834469Q34516390-2B43335F-9B42-4DF9-96B9-E0D9E1A24CA4Q34550656-63A63308-2503-4D91-B84F-11F9F76590D0Q34680409-77A37376-C8B8-4F64-B66F-6841D06091BCQ35005717-E21E8272-ED2A-476E-AE8E-D25CD6380BB5Q35058359-A0C56FD1-8BF7-42D9-9F28-1CC8927A7477Q35191399-193DC5D2-DCC3-4A80-AB13-FC134AF8255BQ35603488-DA6410D5-C59C-475A-A655-3C734C4E56B4Q35619338-FC048E07-3362-4D5D-92C5-781DCECEA8FDQ35623461-44C5E528-5063-4F3F-983C-F7808AC2B732Q35755183-0C29A300-B0ED-4358-963C-D801E389201BQ35911446-1B281CD1-3F09-405D-A583-B87DF25944ABQ35922870-2320A064-9266-4A6A-9D42-23CA56571368Q36360543-ABB99CD1-FE13-4A9E-8ABB-5E1EB912E1EAQ36424324-5E88E3F9-9ED5-4466-997D-73B7966776B9Q36610244-72A4A8A3-9569-4DB2-88F7-4C7AB27E070EQ37214469-D0306571-2228-408A-9018-C0ECC21BA053Q37271681-BA36DBDE-54FB-4532-A15E-6D4A68169D79Q37299619-7F03C9D3-01C3-490C-BDFD-B3942819294EQ37357084-A4D5669F-87CB-46CB-A914-47800B81163AQ37393199-C15AD4C8-3504-45FE-BF3F-230C8BE85C81Q37449986-8C06C23B-43C8-4C8A-B409-EA9E8E72DFCDQ37988384-9C698290-D3E7-4C18-A836-C35C59E7EB2AQ38029327-24462136-993E-453D-8A5E-CCE015361223Q38637960-720869C1-0370-47CA-91C1-4CB50E754203Q38836658-97662387-DAB2-446F-8621-9097857DD8F3Q38854566-43102B44-A40C-46B2-BDCA-5E482945686CQ38963083-A2AF47C9-AA95-4A97-B85A-1620F2261CA2Q39284027-DB82DEA1-06F6-45E2-88EC-080BBD143407
P2860
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Behavioral characterization of ...... f Parkinson's disease in mice.
@ast
Behavioral characterization of ...... f Parkinson's disease in mice.
@en
type
label
Behavioral characterization of ...... f Parkinson's disease in mice.
@ast
Behavioral characterization of ...... f Parkinson's disease in mice.
@en
prefLabel
Behavioral characterization of ...... f Parkinson's disease in mice.
@ast
Behavioral characterization of ...... f Parkinson's disease in mice.
@en
P2093
P1476
Behavioral characterization of ...... f Parkinson's disease in mice.
@en
P2093
Gesine Paul
Paul Mohapel
Ruxandra Iancu
P356
10.1016/J.BBR.2005.02.023
P407
P577
2005-07-01T00:00:00Z